Lysiane Molina

Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group.

Nicole Dastugue, Catherine Payen, Mårina Lafage‐Pochitaloff et al. · PubMed · 1995 · 244 citations

Life Sciences, Hematology, Oncology +16

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

Ibrahim Yakoub‐Agha, Pauline de La Salmonière, Patricia Ribaud et al. · Journal of Clinical Oncology · 2000 · 207 citations

Medicine, Hematology, Oncology +15

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)

Gèrard Socié, J Cahn, Jos Carmelo et al. · British Journal of Haematology · 1997 · 130 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +9

Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study.

Josy Reiffers, Anne Marie Stoppa, Michel Attal et al. · PubMed · 1996 · 109 citations

Medicine, Hematology, Oncology +16

A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.

Josy Reiffers, F. Huguet, Anne Marie Stoppa et al. · PubMed · 1996 · 85 citations

Medicine, Oncology, Pharmacology +12